HECTOR CORZO: Open Payments
NPI 1831272046 · PINELLAS PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,536 in 63 payments from 11 companies in 2025. Trend: 2023 $1,703 · 2024 $830 · 2025 $1,536
Food & beverage: $1,536
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $528 |
| ABBVIE INC. | 11 | $287 |
| Neurocrine BioSciences, Inc. | 8 | $192 |
| Otsuka America Pharmaceutical, Inc. | 5 | $119 |
| Teva Pharmaceuticals USA, Inc. | 4 | $86 |
| E.R. Squibb & Sons, L.L.C. | 3 | $86 |
| Noven Therapeutics, LLC | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $68 |
| Lundbeck LLC | 2 | $46 |
| Alkermes, Inc. | 1 | $34 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, COBENFY, REXULTI, Xelstrym, HETLIOZ, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
